You just read:

Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial

News provided by

Achieve Life Sciences, Inc.

Jun 11, 2019, 07:00 ET